Skip to main content

Tel Aviv University and Industries in India Strengthen their Ties

Bringing together industry and academia of the two countries.

A delegation of the Confederation of Indian Industry (CII) was hosted this week by TAU. The CII is a non-government, not-for-profit, industry-led, and industry-managed organization, with around 9000 members from the private as well as public sectors.

 

CII has an additional, indirect membership of over 300,000 enterprises from 286 national and regional sectoral industry bodies in India. The organization works to create and sustain an environment conducive to India’s development.

 

High-ranking Industry Leaders

The delegation was chaired by Mr. Rajan Navani, Chairman of the CII’s India@75 Council and vice chairman of Jetline Industries. The group included high-ranking industry leaders from India and the United Arab Emirates.

 

In their welcome speech, TAU’s VP International Prof. Milette Shamir and Asia Engagement Director at TAU International, Konstantin Platonov, presented an overview of Tel Aviv University and its academic and research initiatives in India and globally. 

 

Prof. Milette Shamir and Mr. Rajan Navani

 

Multifaceted Relationship

Prof. Yosi Shacham-Diamand, chairman of Nano Scale Information Technologies at TAU Faculty of Engineering, and Prof. Hadas Mamane Steindel, Head of TAU ‘Sustainable Water’ Laboratory discussed some of their most recent projects in India. These included projects on food security, agriculture management, water sustainability, and beyond.

 

The CII delegates participated in an insightful panel on Cyber security issues with Dr. Giora Yaron, founding investor and chairman of the board at Itamar Medical; former TAU chairman Mr. Yigal Unna, and Mr. Nathan Shuchami, managing partner at Hyperwise Ventures.

 

Tel Aviv University has developed a long-standing and multifaceted relationship with CII for several initiatives. These include the India-Israel Forum, a powerful platform that brings together industry and academia of the two countries for an annual conversation on a diverse range of acute topics, such as cyber-security, agriculture technologies, waste management, energy, food and water sustainability and R&D.

 

The 15th gathering of the Forum will take place in India in December 2022 under the auspices of Tel Aviv University, CII, and the Ananta Aspen Center. 

Featured image: The Confederation of Indian Industry (CII) delegation 

TAU Students Team Wins 1st Place in Int’l Mathematics Competition

Team competed with 600 students from leading universities around the world.

An impressive achievement for Tel Aviv University students, who won first prize in a renowned mathematics competition, the International Mathematics Competition (IMC). The competition took place in Blagoevgrad, Bulgaria, with the participation of 600 students from leading universities around the world. At the end of the one-week long competition, the students from Tel Aviv University got the highest group score (292.5 points), as well as the highest individual score.

 

The TAU delegation consisted of 8 students from the School of Mathematical Sciences: Shvo Regavim, Noam Tashma, Lior Hadassi, Shahar Friedman, Lior Schain, Dror Fried, Tommy Winetraub and Uri Kreitner. They were accompanied by team leaders Dr. Dan Carmon and Dor Metzer from the School.

 

Other competition participants came from leading universities, such as: University of Cambridge (England), École Polytechnique (France), Rheinische Friedrich-Wilhelms-Universität Bonn (Germany), University of Amsterdam (Holland), University College London (England), Loránd Eötvös University (Hungary), Barcelona University (Spain).

 

“The competition required a combination of skills: mathematical knowledge at a very high level, along with creativity and the ability to deal with pressure.”

 

Academic Powerhouse in World of Mathematics

The Head of TAU’s School of Mathematical Sciences, Prof. Yaron Ostrover, and the program coordinator, Prof. Yehuda Shalom, congratulated the students, and said: “We are very proud of our students for winning first place in the IMC. Their efforts and commitment, as well as that of their team leader, Dr. Dan Carmon, are praiseworthy.”

 

“TAU’s School of Mathematical Sciences values the preparation of the future generation who will be at the forefront of Israel’s research, science and technology industries. The impressive achievement showcases an important aspect of Israel in general and Tel Aviv University in particular, as an academic powerhouse in the world of mathematics. We also congratulate other universities in Israel for their great achievement.”

 

Dr. Carmon, the team’s math coach and an engineer with StarkWare says: “We competed against some of the best math students in the world, and are very proud of our success. I’d like to congratulate all the Israeli participants for their excellent achievement. The competition required a combination of skills: mathematical knowledge at a very high level, along with creativity and the ability to deal with pressure. I am sure that the skills the students acquired in the competition will serve them in the future as well. In addition, I’d like to thank my colleagues at StarkWare, who helped us with the expenses involved.”

 

Mink the Mascot Works His Magic

Dror Fried, one of the team members, says: “The IMC competition is intended for university students, which means that it also includes integrals, linear algebra, and more. Our students tend to perform well in mathematical competitions, but I did not expect that we’d win the first place in the IMC. I was very happy at the closing ceremony when it was announced. I’m also very grateful to Mink, our group mascot, who helped make it happen.”

 

“Winning is exhilarating,” notes Lior Hadassi. “The atmosphere at the event is very friendly and the medals are just plastic and really not the center of the event, but it’s always fun to win.”

 

Paying respect to Mink

 

“We’re all graduates of the Youth Olympiad, with lots of experience in competitive mathematics. Competitions are always stressful, though. Even the hundredth time around. No matter how prepared you think you are, once the competition starts, your adrenaline flows.”

 

A Meeting of Cultures

“The IMC is a meeting of cultures,” explains Lior. “It was fun to meet teams from all over Europe, from Germany and France, and even from Singapore. I met some friends who I know from the Youth Olympics and who I didn’t think I’d get to see again.”

 

“This is the fifth international competition that I’m competing in, but the first four of them were all in a virtual format because of Covid-19,” says Dror. “So, it was a welcome opportunity to meet everyone. I spoke with quite a few students from around the world. Everyone had interesting things to say about their country, university, the competition itself, or just stories like how the Slovenians steal the Germans’ mascot every year. I’m in touch with some of the participants, and the WhatsApp group of the contestants is still active.”

 

“Competitions are always stressful, though.” adds Lior. “Even the hundredth time around. No matter how prepared you think you are, once the competition starts, your adrenaline flows. The most stressful part is when you’re unable to solve a question and the clock is ticking. On the first day of the competition, I was stuck on a question during three full hours. Only in the last half hour of the test did it occur to me how I should solve it.”

 

“Thank you to Dan Carmon and Dor Metzer, our team leaders, who did a great job organizing our participation and making sure that none of us got lost on the trip. A huge thank you to Lev Radzivilovksi, the head coach of the Israeli math team. Although this time he was not part of the delegation, he cultivated my mathematical abilities and those of many other participants. Without him, Tel Aviv University would not have made this achievement,” concludes Dror.

 

Dror Fried enjoys Bulgarian nature

Making Wheat Rust-Resistant

Researchers respond to the global food crisis by enabling resistance of wheat to rust diseases.

Wheat supplies about one fifth of all calories and proteins consumed by humanity. However, through the millennia, the process of cultivation has reduced the diversity of wheat varieties, and consequently modern wheat varieties are more vulnerable than their predecessors to diseases, pests, and climate hazards. The escalating climate crisis creates an urgent need to produce wheat varieties capable of thriving in extreme environmental and climatic conditions and withstanding pests and diseases.

 

An international research team that includes researchers from Tel Aviv University has isolated three disease-resistance genes from wild grasses, enabling resistance to rust diseases that cause severe damage to wheat yields worldwide.

 

It’s in The Genes

The project was facilitated by several technological innovations that drastically cut down the time needed to identify and isolate genes from wild plant species and transfer them into cultivated plants.

 

“Since wheat first originated in our part of the world, wild cereals growing in our region are the progenitors of cultivated wheat, still carrying a rich variety of genetic traits that can be used to develop improved wheat varieties.”

 

The three genes were isolated from plants preserved in the Liberman Okinow Gene Bank of Wild Cereals at the Institute for Cereal Crops Research (ICCR) at the George S. Wise Faculty of Life Sciences at Tel Aviv University. Two of the genes, providing immunity against stem rust disease, were isolated by an international team led by researchers from the UK. The third gene, isolated by researchers at TAU, provides resistance against two different diseases – leaf rust and stripe rust, currently exacerbated due to rising temperatures around the world.

 

Prof. Amir Sharon, Head of ICCR, says that isolating the genes was enabled by several technological breakthroughs, and that these novel technologies can also be used to isolate genes for other beneficial properties. Transferred into the genome of cultivated wheat, such genes will serve to generate better wheat varieties – featuring higher yields, and resistant to diseases, pests, and harsh environmental conditions. “Just as each of us carries only a small part of his/her grandparents’ genes, cultivated wheat contains only a remnant of its ancient ancestors’ genetic heritage. Since wheat first originated in our part of the world, wild cereals growing in our region are the progenitors of cultivated wheat, still carrying a rich variety of genetic traits that can be used to develop improved wheat varieties,” explains Prof. Sharon.

 

“Certain traits of wild plants have already been incorporated into cultivated wheat over the years, however this great genetic potential remained mostly untapped, since, until recently, it took more than a decade to isolate a single gene. Today, thanks to several technological breakthroughs, especially genome sequencing and bioinformatics, we can isolate new genes in less than a year. Thus, in the past year alone, three genes providing resistance to various rust diseases were isolated from seeds of wild plants preserved in our gene bank. These genes, implanted in cultivated wheat, can significantly reduce damage from the relevant diseases with no need for pesticides – preventing yield losses while also protecting the environment.”

 

In addition to disease resistance, Prof. Sharon’s team is collaborating with researchers worldwide to isolate genes for other beneficial traits. Thus, for example, they work with researchers from Ben-Gurion University who recently isolated pest-resistance genes from wild wheat, and in our own Institute they’ve identified a new gene in wheat progenitors, that may provide endurance in an arid climate.

 

Prof. Amir Sharon & Dr. Arava Shatil Cohen in the lab

 

‘Safe Box’ to Tackle Climate Change

In addition to new methods for isolating genes, great advances have been made in biotechnology, specifically in technologies for gene transfer and genome editing. These technologies enable the transfer of new genes to crop plants, as well as introduction of changes into existing wheat genes.

 

“Essentially, the collection serves as a safe box for genes needed to create new, improved varieties of wheat that will give humanity larger crops and meet the challenges of climate change.”

 

ICCR implements these new technologies, offering services of wheat gene transformation and genome editing to researchers in other institutes, as well as commercial companies. “With the support of the Chief Scientist of Israel’s Ministry of Agriculture, and the Israeli Center for Genome Editing in Agriculture, we have established a center for wheat transformation and genome editing at ICCR,” shares Prof. Sharon. “This is an important milestone, enabling us, for the first time, to perform effective wheat transformation here in Israel,” says Prof. Sharon.

 

Dr. Arava Shatil Cohen, Head of the wheat transformation unit, adds: “With these technologies we can implant new genes and use genome editing methods to give wheat new properties. We utilize our systems to promote research at ICCR and help companies and researchers from other institutions who wish to use this technology”.

 

Today, ICCR’s gene bank includes over 17,000 seeds of 20 different species of wild cereals, collected in Israel over the past 50 years. The collection is unique, both because of its large number of species related to cultivated wheat, and because a large portion of the plants preserved in the gene bank were collected in natural habitats that no longer exist due to rapid urban development in Israel. “Essentially, the collection serves as a safe box for genes needed to create new, improved varieties of wheat that will give humanity larger crops and meet the challenges of climate change,” says Prof. Sharon. “The new technologies are the key to the safe box: they enable us to identify and extract the needed genes quickly and incorporate them into cultivated wheat.”

Like Manna from the Sea

Innovative technology may ease global food crisis: “enriched seaweed” with extremely high nutritional value.

Researchers from Tel Aviv University and the Israel Oceanographic and Limnological Research Institute in Haifa have developed an innovative technology that enables the growth of “enriched seaweed” infused with nutrients, proteins, dietary fiber, and minerals for human and animal needs.

 

According to the researchers, the state-of-the-art technology significantly increases the growth rate, protein levels, healthy carbohydrates, and minerals in the seaweed’s tissues – making the “enriched seaweed” a natural superfood with extremely high nutritional value, which can be used in the future for the health food industry and to secure an unlimited food source.

 

The research was led by Ph.D. student Doron Ashkenazi, under the guidance of Prof. Avigdor Abelson from the School of Zoology, George S. Wise Faculty of Life Sciences at Tel Aviv University and Prof. Alvaro Israel of the Israel Oceanographic and Limnological Research Institute (IOLR) in Tel Shikmona, Haifa. The article was published in the scientific journal Innovative Food Science & Emerging Technologies.

 

“Seaweed can be regarded as a natural superfood, more abundant in the necessary components of the human diet than other food sources.”

 

 

A Natural Superfood

Doron Ashkenazi explains that in the study, local species of the algae Ulva, Gracilaria and Hypnea were grown near fish farming systems under different environmental conditions. The special conditions allowed the seaweed to flourish and enabled a significant improvement in their nutritional value ​​to the point of their becoming “enriched seaweed,” a superfood.

 

“Seaweed can be regarded as a natural superfood, more abundant in the necessary components of the human diet than other food sources,” Ashkenazi adds. “Through the technological approach we developed, a farm owner or entrepreneur will be able to plan in advance a production line of seaweed rich in the substances in which they are interested, which can be used as health foods or nutritional supplements; for example, seaweed with a particularly high level of protein, seaweed rich in minerals such as iron, iodine, calcium, magnesium, and zinc, or in special pigments or anti-oxidants. The enriched seaweed can be used to help populations suffering from malnutrition and nutritional deficiencies, for example disadvantaged populations around the world, as well as supplements to a vegetarian or vegan diet.”

 

In fact, the use of seaweed as a rich food source that meets all human nutritional needs is reminiscent of the biblical manna that fed the Israelites in the desert.

 

Layout of the land-based, outdoor, aquaculture system as was stationed at the IOLR institute, Haifa, Israel

 

“Technologies of this type are undoubtedly a model for a better future for humanity, a future where humans live in idyll and in health in their environment.”

 

Aquaculture, Tomorrow’s Agriculture

Unlike terrestrial agriculture, aquaculture, and in particular the proposed seaweed farming approach, does not require extensive land, fresh water, or large amounts of fertilizer. Environmentally friendly, it preserves nature and the ecological balance by reducing environmental risks. The new methodology, in fact, offers an ideal situation, of sustainable and clean agriculture.

 

Today, integrated aquaculture is beginning to receive support from governments around the world due to its environmental benefits, which include the reduction of nutrient loads to coastal waters and of the emission of gases and carbon footprints. In this way, it contributes to combatting the climate crisis and global warming.

 

“Technologies of this type are undoubtedly a model for a better future for humanity, a future where humans live in idyll and in health in their environment,” concludes Ashkenazi.

 

The research was conducted in collaboration with other leading researchers from around the country, including Guy Paz and Dr. Yael Segal of the Israel Oceanographic and Limnological Research Institute (IOLR) in Haifa, Dr. Shoshana Ben-Valid, an expert in organic chemistry, Dr. Merav Nadav Tsubery of the Department of Chemistry in the Faculty of Exact Sciences at Bar-Ilan University, and Dr. Eitan Salomon from the National Center for Mariculture in Eilat.

Covid-19 Antibodies May Eliminate Need for Boosters

Breakthrough TAU discovery can neutralize all known Covid variants.

A team of Tel Aviv University researchers has demonstrated that antibodies isolated from the immune system of recovered COVID-19 patients are effective in neutralizing all known strains of the virus, including the Delta and the Omicron variants. The discovery may eliminate the need for repeated booster vaccinations and strengthen the immune system of populations at risk.

 

The research was led by Dr. Natalia Freund and doctoral students Michael Mor and Ruofan Lee of the Department of Clinical Microbiology and Immunology at the Sackler Faculty of Medicine and of the TAU Center for Combating Pandemics. The study was conducted in collaboration with Dr. Ben Croker of the University of California San Diego. Prof. Ye Xiang of Tsinghua University in Beijing. Prof. Meital Gal-Tanamy and Dr. Moshe Dessau of Bar-Ilan University also took part in the study. The study was published in the Nature journal Communications Biology.

 

Highly Effective Against Delta and Omicron

The present study is a continuation of a preliminary study conducted in October 2020, at the height of the COVID-19 crisis. At that time, Dr. Freund and her colleagues sequenced all the B immune system cells from the blood of people who had recovered from the original COVID strain in Israel, and isolated nine antibodies that the patients produced. The researchers now found that some of these antibodies are very effective in neutralizing the new coronavirus variants, Delta and Omicron.

 

“In the previous study, we showed that the various antibodies that are formed in response to infection with the original virus are directed against different sites of the virus,” says Dr. Freund. “The most effective antibodies were those that bound to the virus’s ‘spike’ protein, in the same place where the spike binds the cellular receptor ACE2. Of course, we were not the only ones to isolate these antibodies, and the global health system made extensive use of them until the arrival of the different variants of the coronavirus, which in fact rendered most of those antibodies useless.”

 

“In the current study, we proved that two other antibodies, TAU-1109 and TAU-2310, which bind the viral spike protein in a different area from the region where most of the antibodies were concentrated until now (and were therefore less effective in neutralizing the original strain) are actually very effective in neutralizing the Delta and Omicron variants. According to our findings, the effectiveness of the first antibody, TAU-1109, in neutralizing the Omicron strain is 92%, and in neutralizing the Delta strain, 90%. The second antibody, TAU-2310, neutralizes the Omicron variant with an efficacy of 84%, and the Delta variant with an efficacy of 97%.”

 

Can Serve as Effective Substitute for Boosters

According to Dr. Freund, the surprising effectiveness of these antibodies might be related to the evolution of the virus: “The infectivity of the virus increased with each variant because each time, it changed the amino acid sequence of the part of the spike protein that binds to the ACE2 receptor, thereby increasing its infectivity and at the same time evading the natural antibodies that were created following vaccinations.”

 

“In contrast, the antibodies TAU-1109 and TAU-2310 don’t bind to the ACE2 receptor binding site, but to another region of the spike protein – an area of ​​the viral spike that for some reason does not undergo many mutations – and they are therefore effective in neutralizing more viral variants. These findings emerged as we tested all the known COVID strains to date.”

 

“In our view, targeted treatment with antibodies and their delivery to the body in high concentrations can serve as an effective substitute for repeated boosters, especially for at-risk populations and those with weakened immune systems.” 

 

The two antibodies, cloned in Dr. Freund’s laboratory at Tel Aviv University, were sent for tests to check their effectiveness against live viruses in laboratory cultures at the University of California San Diego, and against pseudo viruses in the laboratories of the Faculty of Medicine of Bar-Ilan University in the Galilee; the results were identical and equally encouraging in both tests.

 

Dr. Freund believes that the antibodies can bring about a real revolution in the fight against COVID-19: “We need to look at the COVID-19 pandemic in the context of previous disease outbreaks that humankind has witnessed. People who were vaccinated against smallpox at birth and who today are 50 years old still have antibodies, so they are probably protected, at least partially, from the monkeypox virus that we have recently been hearing about. Unfortunately, this is not the case with the coronavirus. For reasons we still don’t yet fully understand, the level of antibodies against COVID-19 declines significantly after three months, which is why we see people getting infected again and again, even after being vaccinated three times.”

 

“In our view, targeted treatment with antibodies and their delivery to the body in high concentrations can serve as an effective substitute for repeated boosters, especially for at-risk populations and those with weakened immune systems. COVID-19 infection can cause serious illness, and we know that providing antibodies in the first days following infection can stop the spread of the virus. It is therefore possible that by using effective antibody treatment, we will not have to provide booster doses to the entire population every time there is a new variant.”

Featured image: Dr. Natalia Freund from the Sackler Faculty of Medicine (Photo: Yoram Reshef)

Stop Blaming the Bats for Covid-19

Researchers conclude there’s insufficient proof of correlation between bats and the outbreak of the epidemic.

Shortly after outbreak of the Corona epidemic, accusations were voiced among the public, as well as within the scientific community, claiming that the bats are considered a health threat, as reservoirs of viruses’, including the Covid-19 virus. A new Tel Aviv University study rejects this correlation between the Covid-19 outbreak and bats, which the researchers say was not based on sufficient compelling scientific proof. Bats have a highly effective immune system that enables them to deal relatively easily with viruses that are considered lethal for other mammals.

Bats with a Bad Rap

The study was led by Dr. Maya Weinberg from the laboratory of Prof. Yossi Yovel, Head of the Sagol School of Neuroscience and faculty member of the School of Zoology and the Steinhardt Museum of Natural History at Tel Aviv University. The research team reviewed dozens of leading articles and studies in this field, and their conclusions were published in writing in the prestigious iScience Journal.

The researchers explain that the infamous reputation of the bats is well known among both the scientific community and the public at large, namely that they are often accused of being reservoirs of viruses including Covid-19, thus posing a threat to public health. While there is indeed evidence that the origin of the “ancient potential” Covid-19 was in bats, the researchers note that two years after the pandemic first broke out, we still do not know for sure what the exact origin of the COVID-19 variant is.

 

“Bats have a highly effective immune system that enables them to deal relatively easily with viruses considered lethal for other mammals.”

 

Dr. Weinberg: “In general, bats are mistakenly conceived of as reservoirs of many contagious disease, only due to their being positive serologically positive; in other words, in possession of antibodies, which means that bats have survived the disease and developed an immune response. After that, they overcame the virus altogether and disengaged from it; hence, they are no longer its carriers. Nevertheless, in many cases, a virus similar to a human pathogen is liable to be found in bats; however, it is not pathogenic to humans, and is not sufficient to use bats as a reservoir.”

 

Dr. Weinberg with a friend

Capable of Coping with Different Viruses

To examine the overall situation, the researchers conducted a meta-analysis of literature on over 100 viruses for which bats are considered potential reservoirs, including Ebola, SARS, and COVID. “We found that in a considerable number of cases (48%) this claim was based on the incidence of antibodies or PCR tests, rather than actual isolation of identical viruses. Moreover, many of the reported findings are not convincing,” says Dr. Weinberg.

“The mere isolation of a virus is not enough to see an animal as a reservoir, since a minimum number of index cases is required in which the virus is isolated in order to be considered a reservoir animal, as well as the existence of an established path of transmission. Furthermore, the very detection of a particular virus in bats does not necessarily ensure further infection. Additional biological, ecological, and anthropogenic conditions must exist for such an event to occur.”

According to the researchers, simultaneously, in recent years evidence is accumulating of the fact that bats are capable of coping with different viruses, including lethal ones, better than humans and most other mammals. After over 100 years of focus on viruses carried by bats, it appears that bats’ immune system is characterized by a restrained response during inflammatory processes. As we see it, bats have developed an excellent balance between resistance and tolerance: an increased defense response of the host, and immune tolerance through a number of different mechanisms. Moderate inflammatory pathways contribute to immune tolerance with bats, and a well-balanced response that prevents the virus from developing.

 

“The comprehensive study we’ve conducted raises serious doubts regarding the possibility of bats being the origin of the Covid19 outbreak. The findings give rise to the opposite perspective, according to which we must study in-depth the immunological anti-viral capabilities of bats, and thus obtain new and effective means of coping in humanity’s struggle against contagious disease, aging, and cancer,” concludes Dr. Weinberg.

Featured image: Wouldn’t hurt a fly? (Photo: Yuval Barkai)

Eradicating Deadly Brain Tumors by ‘Starvation’

A groundbreaking study at Tel Aviv University effectively eradicated glioblastoma, a highly lethal type of brain cancer. The researchers achieved the dramatic outcome using a method they developed based on their discovery of two critical mechanisms in the brain that support tumor growth and survival: one protects cancer cells from the immune system, while the other supplies the energy required for rapid tumor growth. The researchers found that both mechanisms are controlled by brain cells called astrocytes, and in their absence, the tumor cells die and are eliminated.

The study was led by Ph.D. student Rita Perelroizen, under the supervision of Dr. Lior Mayo of the Shmunis School of Biomedicine and Cancer Research and the Sagol School of Neuroscience, in collaboration with Prof. Eytan Ruppin of the National Institutes of Health (NIH) in the USA. The paper was published in the scientific journal Brain and was highlighted with special commentary.

Focusing on Tumor Environment

The researchers explain: “Glioblastoma is an extremely aggressive and invasive brain cancer, for which there exists no known effective treatment. The tumor cells are highly resistant to all known therapies, and, sadly, patient life expectancy has not increased significantly in the last 50 years. Our findings provide a promising basis for the development of effective medications for treating glioblastoma and other types of brain tumors.”

“We tackled the challenge of glioblastoma from a new angle,” explains Dr. Mayo. “Instead of focusing on the tumor, we focused on its supportive microenvironment, that is, the tissue that surrounds the tumor cells.”

 

“In the absence of astrocytes, the tumor quickly disappeared, and in most cases, there was no relapse – indicating that the astrocytes are essential to tumor progression and survival.”

“Specifically, we studied astrocytes – a major class of brain cells that support normal brain function, discovered about 200 years ago and named for their starlike shape. Over the past decade, research from us and others revealed additional astrocyte functions that either alleviate or aggravate various brain diseases. Under the microscope we found that activated astrocytes surrounded glioblastoma tumors. Based on this observation, we set out to investigate the role of astrocytes in glioblastoma tumor growth.”

Using a lab model, in which they could eliminate active astrocytes around the tumor, the researchers found that in the presence of astrocytes, the cancer killed all lab models with glioblastoma tumors within 4-5 weeks. Applying a unique method to specifically eradicate the astrocytes near the tumor, they observed a dramatic outcome: the cancer disappeared within days, and all treated lab models survived. Moreover, even after discontinuing treatment, most of the lab models survived.

WATCH: Dr. Lior Mayo explains the dramatic breakthrough in addressing glioblastoma, a deadly brain cancer

 

Exposing Mechanisms of Double Agents

“In the absence of astrocytes, the tumor quickly disappeared, and in most cases, there was no relapse – indicating that the astrocytes are essential to tumor progression and survival,” notes Dr. Mayo. “Therefore, we investigated the underlying mechanisms: How do astrocytes transform from cells that support normal brain activity into cells that support malignant tumor growth?”

To answer these questions, the researchers compared the gene expression of astrocytes isolated from healthy brains and from glioblastoma tumors. They found two main differences – thereby identifying the changes that astrocytes undergo when exposed to glioblastoma:

  1. The first change was in the immune response to glioblastoma. Dr. Mayo clarifies, “The tumor mass includes up to 40% immune cells – mostly macrophages recruited from the blood or from the brain itself. Furthermore, astrocytes can send signals that summon immune cells to places in the brain that need protection. In this study, we found that astrocytes continue to fulfill this role in the presence of glioblastoma tumors. However, once the summoned immune cells reach the tumor, the astrocytes ‘persuade’ them to ‘change sides’ and support the tumor instead of attacking it. Specifically, we found that the astrocytes change the ability of recruited immune cells to attack the tumor both directly and indirectly – thereby protecting the tumor and facilitating its growth.”
  2. The second change through which astrocytes support glioblastoma is by modulating their access to energy – via the production and transfer of cholesterol to the tumor cells. The malignant glioblastoma cells divide rapidly, a process that demands a great deal of energy. With access to energy sources in the blood barred by the blood-brain barrier, they must obtain this energy from the cholesterol produced in the brain itself – namely in the astrocytes’ ‘cholesterol factory’, which usually supplies energy to neurons and other brain cells. “We discovered that the astrocytes surrounding the tumor increase the production of cholesterol and supply it to the cancer cells,” explains Dr. Mayo. “Therefore, we hypothesized that, because the tumor depends on this cholesterol as its main source of energy, eliminating this supply will starve the tumor.”

The Tumor’s Vulnerability, a Therapeutic Opportunity

Next, the researchers engineered the astrocytes near the tumor to stop expressing a specific protein that transports cholesterol (ABCA1), thereby preventing them from releasing cholesterol into the tumor. Once again, the results were dramatic: with no access to the cholesterol produced by astrocytes, the tumor essentially ‘starved’ to death in just a few days. These remarkable results were obtained in both lab models and glioblastoma samples taken from human patients and are consistent with the researchers’ starvation hypothesis.

 

“The challenge now, is to develop drugs that target the specific processes in the astrocytes that promote tumor growth. Alternately, existing drugs may be repurposed to inhibit mechanisms identified in this study.”

 

Dr. Mayo notes: “This work sheds new light on the role of the blood-brain barrier in treating brain diseases. The normal purpose of this barrier is to protect the brain by preventing the passage of substances from the blood to the brain. But in the event of a brain disease, this barrier makes it challenging to deliver medications to the brain and is considered an obstacle to treatment. Our findings suggest that, at least in the specific case of glioblastoma, the blood-brain barrier may be beneficial to future treatments, as it generates a unique vulnerability – the tumor’s dependence on brain-produced cholesterol. We think this weakness can translate into a unique therapeutic opportunity.”

The project also examined databases from hundreds of human glioblastoma patients and correlated them with the results described above. The researchers explain: “For each patient, we examined the expression levels of genes that either neutralize the immune response or provide the tumor with a cholesterol-based energy supply. We found that patients with low expression of these identified genes lived longer, thus supporting the concept that the genes and processes identified are important to the survival of glioblastoma patients.”

“Currently, tools to eliminate the astrocytes surrounding the tumor are available in lab models, but not in humans,” notes Dr. Mayo. “The challenge now, is to develop drugs that target the specific processes in the astrocytes that promote tumor growth. Alternately, existing drugs may be repurposed to inhibit mechanisms identified in this study. We think that the conceptual breakthroughs provided by this study will accelerate success in the fight against glioblastoma. We hope that our findings will serve as a basis for the development of effective treatments for this deadly brain cancer and other types of brain tumors,” he concludes.

Can Music Help Prevent Severe Cognitive Decline?

TAU researchers developed musical tests to detect mental deterioration in old age.

Modern technology contributes to increased longevity and thus to the growth of the elderly population. It is therefore important to take steps to ensure their quality of life, including inventing tools for accessible and quick diagnosis of age-related conditions. While preventative tests are commonly accepted for a variety of physiological problems such as diabetes, high blood pressure or breast cancer, no method has yet been developed to enable routine, accessible monitoring of the brain for cognitive issues.

 

Researchers at Tel Aviv University have developed a method that employs musical tests and a portable instrument for measuring brain activity to detect cognitive decline in old age. The method entails measuring 15 minutes of electrical activity in the subject’s brain while he or she performs simple musical tasks and can be easily implemented by any staff member in any clinic, without requiring special training. The researchers believe the method could pave the way towards early detection of cognitive decline when treatment and prevention of severe decline are possible, improving the quality of life of millions around the world

 

Many Powers of Music

The study was led at Tel Aviv University by PhD student Neta Maimon from the School of Psychological Sciences and the Buchmann-Mehta School of Music, and Lior Molcho from Neurosteer Ltd, headed by Prof. Nathan Intrator from the Blavatnik School of Computer Science and the Sagol School of Neuroscience. Other participants included: Adi Sasson, Sarit Rabinowitz, and Noa Regev-Plotnick from the Dorot-Netanya Geriatric Medical Center. The article was published in the journal Frontiers in Aging Neuroscience.

 

As part of the study, the researchers developed a groundbreaking method combining a portable device for the measurement and innovative analysis of electroencephalography (EEG), developed by Neurosteer, and a short musical test of about 12-15 minutes, developed by Maimon.

 

“We have actually succeeded in illustrating that music is indeed an effective tool for measuring brain activity.”

 

Maimon, who specializes in musical cognition, explains that music has great influence on different centers in the brain. On the one hand, music is known to be a quick mood stimulant, particularly of positive emotion. On the other hand, in different situations, music can be cognitively challenging, activating the frontal parts of the brain, especially if we try to concentrate on different aspects of the music, and at the same time perform a particular task. According to Maimon, if we combine these two capabilities, we can create cognitive tests that are quite complex, yet also pleasant and easy to perform.

 

Neta Maimon specializes in musical cognition

 

Furthermore, music that is positive and reasonably rhythmic will enhance concentration and performance of the task. Thus, for example, the famous “Mozart effect,” whereby subjects perform better on intelligence tests after listening to Mozart’s music, has nothing to do with Mozart’s music, but rather the fact that music creates a positive mood and stimulates us to a state that is optimal for performing intelligence and creativity tests.

 

Accordingly, the researchers hypothesized that with musical tools, it would also be possible to challenge the subjects to an extent that would enable testing of the brain’s frontal activity as well as raising their spirits, thus enhancing their performance on the test while the overall experience is pleasant.

 

Enabling Early Detection of Cognitive Decline

The study included an experiment testing 50 elderly people hospitalized at the Dorot-Netanya Geriatric Medical Center. “Anyone hospitalized at Dorot, or any other geriatric rehabilitation institution, undergoes a standard test called ‘mini-mental,’ designed to evaluate their cognitive condition as a routine part of the intake process,” explains Maimon.

 

During the test, the subject is connected to the portable EEG device by means of an adhesive band with three electrodes attached to the forehead. The test includes a variety of tasks, including enumerating the days of the week or months of the year backwards. The subject performs a series of musical-cognitive tasks according to audible instructions given automatically through earphones. Short melodies are played by different instruments, and the subjects are instructed to perform various tasks on them at varying levels of difficulty. For example, pressing a button each time any melody is played or pressing it only when the violin plays. In addition, the test includes several minutes of musically guided meditation designed to bring the brain to a resting state, as this state is known to indicate cerebral functioning in various situations. Up to 30 points can be accrued, a high score indicating normal cognition.

 

“Our method enables the monitoring of cognitive capability and detection of cognitive decline already in the early stages, all by simple and accessible means.”

 

“The participants scored 18-30 on the mini-mental test, indicating various levels of cognitive functioning,” explains Maimon. “The EEG device registered the electrical activity in the brain during the activity, and the results were analyzed using machine learning technology. This allowed mathematical indices to be identified that were precisely correlated with the mini-mental test scores; in other words, we obtained new neuro-markers [brain markers] that may stand alone as indices of the subject’s cognitive status.”

 

Maimon adds: “We have actually succeeded in illustrating that music is indeed an effective tool for measuring brain activity. The brain activity and response times to tasks correlated to the subjects’ cerebral conditions (correlating to the mini-mental score assigned to them). More importantly, all those who underwent the experiment reported that, on the one hand, it challenged the brain, but on the other it was very pleasant to perform”.

 

The researchers conclude: “Our method enables the monitoring of cognitive capability and detection of cognitive decline already in the early stages, all by simple and accessible means, with a quick and easy test that can be conducted in any clinic. This method is of special importance today due to the increase in longevity and accelerated population growth, particularly among the elderly. Today, millions of people around the world already suffer or are liable to suffer soon from cognitive decline and its dire consequences, and their number will only increase in the coming decades. Our method could pave the way towards efficient cognitive monitoring of the general population, and thus detect cognitive decline in its early stages, when treatment and prevention of severe decline are possible. It is therefore expected to improve the quality of life of millions around the world.”

TAU Launches Israel’s 1st Scholarship Program for International Student-Athletes

Initiative will enable elite athletes to study and train at world-class facilities, boost Israeli sports performance.

Tel Aviv University today announced the launch of a new scholarship program for international student-athletes, making it the first of its kind at a university in Israel. TAU is due to welcome the first cohort of recipients to campus in the next academic year.  

The International Sports Scholarship Fund at TAU was established through a generous gift from Israeli-British philanthropist and TAU Governor Linda Streit.

Raising the Bar for Israeli Sports

The Scholarship Fund will provide full degree support for talented athletes between the ages of 17-30, each year. International applicants of all nationalities are eligible.

Scholarship recipients will have the opportunity to study or research in any of TAU International’s nearly two dozen English-taught programs and train at the University’s world-class academic and sports facilities. Recipients will be expected to participate in elite Israeli sports by, for example, competing for the country in international competitions.  

Elite athletics in Israel, including Olympic representation, have gained steady momentum in recent years. This has been reinforced at TAU through the establishment of the Sylvan Adams Sports Institute (SASI), the first applied sports research facility of its kind in Israel for nurturing the performance of world-class athletes and Olympians such as TAU medical student and swimmer Andrea “Andi” Murez, as well as the recent overhaul plans for the University to provide students with the highest caliber training equipment and facilities.  

 

Andi Murez (Photo: Moshe Bedarshi/TAU)

Scholarship recipients will be selected by a committee of representatives from Tel Aviv University International (TAUi)—TAU’s division for international academics and activities—SASI, and Israeli sports professionals, including those affiliated with the competitive sports association at TAU’s Sports Center. The scholarships are available for athletes in all sports in which Israel’s national teams compete.  

Fueling Olympic Dreams

Linda Streit lectured at TAU’s Department of English and American Studies for over 30 years and is Co-Chair of the University’s Student Affairs Committee. Her family founded the Daniel Amichai Center for Rowing and Nautical Studies in Tel Aviv in memory of her late son, an avid rower who tragically died at the age of 21.

“I established the Daniel Howard Foundation (DHF) in memory of my son Daniel, an elite rower who was training to represent Israel in international competitions,” says Streit. “The foundation’s strategy is to support excellence in sport, and my dream is that an athlete representing Israel will be standing on the Olympic podium where Daniel was supposed to stand.”

The family’s philanthropic legacy at TAU began with her late grandparents, Sir John (“Jack”) and Lady Sarah Cohen and now spans five generations of engagement. Streit’s father, the late Sir Leslie Porter, was a former TAU Chancellor, Chairman of the University’s Board of Governors, and a generous benefactor. Among the numerous campus initiatives established by the family is the landmark Porter School of Environment and Earth Sciences, which Streit’s parents, Sir Leslie Porter and Dame Shirley Porter, founded in 2000. The school has grown into a thriving academic unit with a strong record of promoting environmental initiatives both within and outside of academia. 

“This scholarship program allows talented international athletes to choose Tel Aviv University as the venue for achieving success in high-level sports and studies,” Streit adds. 

Winning Big in Athletics and Academics 

TAU Vice President of International Collaboration Prof. Milette Shamir: “We are thrilled to roll out Israel’s first initiative to foster the education and careers of elite international athletes, who often must choose between academia or professional sports.”

She adds that “Sports are universally appreciated and an invaluable channel for bringing people together. This initiative is the latest among several recent steps at TAU for enhancing world-class sports in Israel, and thereby, the country’s recognition on the global stage.” 

For more information or to arrange prospective applicant consultations, please contact David Ryan, Global Outreach & Recruitment Manager at TAUi: [email protected]  

Scientific discovery may facilitate speedy, objective, and accurate diagnosis of the condition using saliva

Scientific discovery may facilitate speedy, objective, and accurate diagnosis of the condition using saliva.

A scientific breakthrough from the Tel Aviv and Haifa Universities may facilitate speedy, objective, and accurate diagnosis of people suffering from posttraumatic stress disorder, PTSD, using saliva samples, as well as developing microbiotic related medications (associated with the body’s microbial ecology).

 

The study was a joint effort by eminent scholars from various fields. It was led by Professor Illana Gozes and included Professor Noam Shomron, Dr. Shlomo Sragovich and Ph.D. student Guy Shapira, (all from TAU’s Sackler Faculty of Medicine and Sagol School of Neuroscience) as well as Prof. Zahava Solomon from TAU’s Gershon H. Gordon Faculty of Social Sciences, and Prof. Abraham Sagi-Schwartz and PhD student Ella Levert-Levitt from the Center for the Study of Child Development and the School of Psychological Sciences at Haifa University. The study was published in NATURE‘s prestigious MOLECULAR PSYCHIATRY magazine.

 

Diagnosing PTSD by Objective Criteria

The researchers tested a unique group of about 200 Israeli veteran soldiers (they all came from a larger cohort of subjects from a comprehensive four-decade-long study of veterans by Prof. Solomon) who had fought in the first Lebanon War in 1982. The test covered various psychological aspects, including sleep, appetite disorders, guilt, suicidal thoughts, social and spousal support, hostility, satisfaction with life, as well as issues of demographics, psychopathology, welfare, health, and education.

 

“We were surprised to discover that about a third of the PTSD subjects had never been diagnosed with post-trauma, so they never received any recognition from the Ministry of Defense and the official authorities.”

 

The researcher also collected saliva samples from them and comparing the results of the subjects’ microbial distribution to the psychological results and their responses to the welfare questionnaires, the researchers from the universities of Tel Aviv and Haifa found that people with PTSD and high psychopathological indications exhibit the same picture of bacteria in the saliva (a unique oral microbiotic signature).

According to the researchers, this study is significant in that for the first time, we might be able to diagnose post-trauma by objective criteria and not just behavioral ones.

One Third of Soldiers Were Undiagnosed

It is interesting to note here that the saliva bacteria of those exposed to air pollution showed a correlation to the picture with PTSD, while the number of years of education showed a protective influence and a reverse picture of the microbial ecology in the saliva. 

 

“To the best of our knowledge, this is the first depiction of a microbial signature in the saliva among veteran soldiers with PTSD,” says Prof. Illana Gozes. “We were surprised to discover that about a third of the PTSD subjects had never been diagnosed with post-trauma, so they never received any recognition from the Ministry of Defense and the official authorities.”

 

“To the best of our knowledge, this is the first depiction of a microbial signature in the saliva among veteran soldiers with PTSD,”

 

“It must be stressed that until now, post-trauma diagnosis has been based solely on psychological and psychiatric measures. Thanks to this study, it may be possible, in the future, to use objective molecular and biological characteristics to distinguish PSTD sufferers, taking into account environmental influences. We hope that this new discovery and the microbial signatures described in this study might promote easier diagnosis of post-traumatic veteran soldiers so they can receive appropriate treatment.”

The study was also supported by IDF’s Medical Corps Department of Health and Well-Being and Dr. Ariel Ben Yehuda, former chief of the above Department and currently, a Department Manager in the Mental Health Medical Center in Shalvata, Clallit Health Services. The study also involved collaboration with the Charité University Medicine in Berlin and its microbiology experts Dr. Markus M. Heimesaat and Professor Stefan Bereswill, as well as with the University of Hong Kong, which is studying the effects of air pollution, Professors Victor Li and Jacqueline Lam.

Victoria

Tok Corporate Centre, Level 1,
459 Toorak Road, Toorak VIC 3142
Phone: +61 3 9296 2065
Email: [email protected]

New South Wales

Level 22, Westfield Tower 2, 101 Grafton Street, Bondi Junction NSW 2022
Phone: +61 418 465 556
Email: [email protected]

Western Australia

P O Box 36, Claremont,
WA  6010
Phone: :+61 411 223 550
Email: [email protected]